Form 8-K - Current report:
SEC Accession No. 0001213900-24-112685
Filing Date
2024-12-26
Accepted
2024-12-26 16:30:07
Documents
13
Period of Report
2024-12-23
Items
Item 1.02: Termination of a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0226033-8k_china.htm   iXBRL 8-K 23672
  Complete submission text file 0001213900-24-112685.txt   198519

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cphi-20241223.xsd EX-101.SCH 3048
3 XBRL LABEL FILE cphi-20241223_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE cphi-20241223_pre.xml EX-101.PRE 22381
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0226033-8k_china_htm.xml XML 3779
Mailing Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216
Business Address 2ND FLOOR, NO. 17, JINPAN ROAD HAIKOU HAINAN PROVINCE F4 570216 8689866811730
CHINA PHARMA HOLDINGS, INC. (Filer) CIK: 0001106644 (see all company filings)

EIN.: 731564807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34471 | Film No.: 241581373
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)